Page last updated: 2024-08-18

4-butyrolactone and Bladder Cancer

4-butyrolactone has been researched along with Bladder Cancer in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, CY; Hsu, YL; Kuo, PL; Lin, ES; Shen, KH	1

Other Studies

1 other study(ies) available for 4-butyrolactone and Bladder Cancer

Article	Year
Isolinderanolide B, a butanolide extracted from the stems of Cinnamomum subavenium, inhibits proliferation of T24 human bladder cancer cells by blocking cell cycle progression and inducing apoptosis. Integrative cancer therapies, 2011, Volume: 10, Issue:4 Topics: 4-Butyrolactone; Apoptosis; Caspase 8; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Cinnamomum; Cyclin-Dependent Kinase Inhibitor p21; Fas Ligand Protein; fas Receptor; Humans; Plant Extracts; Plant Stems; Tumor Suppressor Protein p53; Urinary Bladder Neoplasms	2011

Article

Year

Isolinderanolide B, a butanolide extracted from the stems of Cinnamomum subavenium, inhibits proliferation of T24 human bladder cancer cells by blocking cell cycle progression and inducing apoptosis.

Integrative cancer therapies, 2011, Volume: 10, Issue:4

Topics: 4-Butyrolactone; Apoptosis; Caspase 8; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Cinnamomum; Cyclin-Dependent Kinase Inhibitor p21; Fas Ligand Protein; fas Receptor; Humans; Plant Extracts; Plant Stems; Tumor Suppressor Protein p53; Urinary Bladder Neoplasms

2011